Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

FANCM is the most highly conserved protein within the Fanconi anaemia (FA) tumour suppressor pathway. However, although FANCM contains a helicase domain with translocase activity, this is not required for its role in activating the FA pathway. Instead, we show here that FANCM translocaseactivity is essential for promoting replication fork stability. We demonstrate that cells expressing translocase-defective FANCM show altered global replication dynamics due to increased accumulation of stalled forks that subsequently degenerate into DNA double-strand breaks, leading to ATM activation, CTBP-interacting protein (CTIP)-dependent end resection and homologous recombination repair. Accordingly, abrogation of ATM or CTIP function in FANCM-deficient cells results in decreased cell survival. We also found that FANCM translocase activity protects cells from accumulating 53BP1-OPT domains, which mark lesions resulting from problems arising during replication. Taken together, these data show that FANCM plays an essential role in maintaining chromosomal integrity by promoting the recovery of stalled replication forks and hence preventing tumourigenesis.

Original publication

DOI

10.1093/hmg/dds013

Type

Journal article

Journal

Hum Mol Genet

Publication Date

01/05/2012

Volume

21

Pages

2005 - 2016

Keywords

Animals, Ataxia Telangiectasia Mutated Proteins, Cell Cycle Proteins, Cell Line, DNA Breaks, Double-Stranded, DNA Helicases, DNA Repair, DNA Replication, DNA-Binding Proteins, Fanconi Anemia, Gene Knockout Techniques, HEK293 Cells, HeLa Cells, Homologous Recombination, Humans, Intracellular Signaling Peptides and Proteins, Models, Biological, Nucleotide Transport Proteins, Protein-Serine-Threonine Kinases, RNA, Small Interfering, Tumor Suppressor Proteins, Tumor Suppressor p53-Binding Protein 1